Metraipolis › archive › dc_53bd4d0addf7
Dysregulation of sphingolipid-metabolizing enzymes in Friedreich's ataxia: In vitro and in vivo insights into therapeutic targeting — Europe PMC PMID:42383006
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42383006
- DOI
- 10.1016/j.isci.2026.116479
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T07:03:46.826Z
- SHA-256 of the archived text
bbc21b07aa20b7fc2ed8902d31384e254bdf5130eead095a937f250bdb3c0ebe- Stable URL of this page
https://metraipolis.com/documento/dc_53bd4d0addf7
How to cite
Dysregulation of sphingolipid-metabolizing enzymes in Friedreich's ataxia: In vitro and in vivo insights into therapeutic targeting — Europe PMC PMID:42383006 — Europe PMC (en), https://europepmc.org/article/MED/42383006 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_53bd4d0addf7 (Metraipolis archive dc_53bd4d0addf7, sha256 bbc21b07aa20b7fc2ed8902d31384e254bdf5130eead095a937f250bdb3c0ebe)
BibTeX
@misc{dc53bd4d0addf7,
title = {Dysregulation of sphingolipid-metabolizing enzymes in Friedreich's ataxia: In vitro and in vivo insights into therapeutic targeting — Europe PMC PMID:42383006},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42383006},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_53bd4d0addf7; sha256 bbc21b07aa20b7fc2ed8902d31384e254bdf5130eead095a937f250bdb3c0ebe},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42383006. Agents can read the archived copy with the MCP tool read_document.